Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07833709

Effectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia

Misophonia is characterized by strong emotional and physiological reactions to specific trigger sounds and may interfere with daily functioning and emotional well-being. This randomized controlled trial will evaluate the effectiveness of a mobile application based on mindfulness-based cognitive behavioral interventions for adults with misophonia symptoms.

A total of 60 participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will use a three-week mobile intervention that includes psychoeducation, cognitive behavioral techniques, gradual exposure to trigger sounds, mindfulness, breathing and relaxation exercises, and self-monitoring tools. The control group will not receive the mobile intervention during the study period.

Outcomes will be assessed before the intervention, immediately after the three-week intervention, and four weeks after the intervention. The main outcome will be change in misophonia symptoms. Secondary outcomes will include depression, anxiety, stress, and difficulties in emotion regulation.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sakarya University, Faculty of Health Sciences

Sakarya, Sakarya Üniversitesi, 54050, Turkey (Türkiye)

Location contact

Sevgi Koroglu Gokbel, MSc

CONTACT

[email protected]

+90 264 295 74 28

About this study

This study is a randomized controlled trial designed to evaluate the effectiveness of a mobile application based on mindfulness-based cognitive behavioral interventions for individuals with misophonia symptoms.

The mobile intervention was developed to address cognitive, emotional, behavioral, and physiological processes associated with misophonia. The intervention integrates psychoeducation, cognitive behavioral therapy, mindfulness-based strategies, gradual exposure and desensitization, breathing and relaxation exercises, and self-monitoring. The intervention specifically targets threat appraisal, automatic thoughts, avoidance behaviors, physiological arousal, and difficulties in emotion regulation.

A total of 60 eligible participants will be randomly assigned to an intervention group or a control group using stratified block randomization. The intervention group will receive access to the mobile application for three weeks. The application includes educational content about misophonia, identification of individual trigger sounds, cognitive restructuring exercises, a thought diary, graded exposure to trigger sounds, Subjective Units of Distress Scale (SUDS) monitoring, breathing exercises, mindfulness practices, relaxation tools, and supportive audio content. The exposure component includes graded exposure, distress monitoring, breathing support, and a safe-stop option.

Participants will be evaluated at three time points: baseline before the intervention, immediately after completion of the three-week intervention, and four weeks after the intervention. The primary outcome will be change in misophonia symptoms. Secondary outcomes will include depression, anxiety, stress, and difficulties in emotion regulation. These outcomes will be assessed using the Misophonia Scale, the Depression Anxiety Stress Scale-21 (DASS-21), and the 16-item Difficulties in Emotion Regulation Scale.

The study will examine whether the mobile intervention produces improvements in misophonia symptoms and related psychological outcomes compared with the control condition.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • Meeting the misophonia criteria proposed by Jager et al. (2020).
  • Reporting at least one trigger sound.
  • Having a Misophonia Scale total score greater than 60.5.
  • Owning a smartphone or tablet.
  • Having sufficient technological literacy to use the mobile application.

Exclusion criteria

  • Misophonia symptoms being better explained by another condition or disorder based on the eligibility screening.
  • A Misophonia Scale total score of 60.5 or lower.
  • Development of marked distress or functional impairment during the study that requires discontinuation and referral for professional mental health support.

Treatment and study plan

Mindfulness-Based Cognitive Behavioral Mobile Intervention

Behavioral

A three-week mobile behavioral intervention developed for adults with misophonia symptoms. The intervention integrates psychoeducation, cognitive behavioral techniques, self-monitoring, cognitive restructuring, graded exposure to trigger sounds, Subjective Units of Distress Scale (SUDS) monitoring, mindfulness practices, breathing exercises, relaxation techniques, and supportive audio content. The program is designed to target maladaptive thoughts, avoidance behaviors, emotional reactivity, physiological arousal, and difficulties in emotion regulation associated with misophonia.

Primary outcomes

  1. Change in Misophonia Scale Total Score

    Time frame: Baseline, 3 weeks, and 7 weeks

    Misophonia symptoms will be assessed using the 30-item Misophonia Scale developed by Koroglu and Durat (2024). Each item is rated on a 5-point Likert scale, yielding a total score ranging from 30 to 150. Higher scores indicate lower misophonia severity, whereas lower scores indicate greater misophonia severity. Changes in total scores will be compared between the intervention and control groups.

Secondary outcomes

  1. Change in DASS-21 Depression Subscale Score

    Time frame: Baseline, 3 weeks, and 7 weeks

    Depressive symptoms will be assessed using the Depression subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of depressive symptoms. Changes in depression scores will be compared between the intervention and control groups.

  2. Change in DASS-21 Anxiety Subscale Score

    Time frame: Baseline, 3 weeks, and 7 weeks

    Anxiety symptoms will be assessed using the Anxiety subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of anxiety symptoms. Changes in anxiety scores will be compared between the intervention and control groups.

  3. Change in DASS-21 Stress Subscale Score

    Time frame: Baseline, 3 weeks, and 7 weeks

    Stress symptoms will be assessed using the Stress subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of stress symptoms. Changes in stress scores will be compared between the intervention and control groups.

  4. Change in Difficulties in Emotion Regulation Scale-16 (DERS-16) Total Score

    Time frame: Baseline, 3 weeks, and 7 weeks

    Difficulties in emotion regulation will be assessed using the 16-item Difficulties in Emotion Regulation Scale (DERS-16). The scale consists of 16 items rated on a 5-point Likert scale. Higher total scores indicate greater difficulties in emotion regulation. Changes in DERS-16 total scores will be compared between the intervention and control groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Sevgi Koroglu Gokbel, Research Assistant

CONTACT

[email protected]

+90 264 295 74 28

Sponsors and collaborators

Lead sponsor

Sakarya University

Other

Collaborators

  • The Scientific and Technological Research Council of Turkey

Registry information

Official study title

Effectiveness of a Mobile Application Based on Mindfulness-Based Cognitive Behavioral Interventions for the Management of Misophonia: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 22, 2026
Registry last updated
Sep 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.